Mustang Bio Inc (MBIO)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $3.20M
Last updated: Nov 17, 2026 at 4:10 PM ET
Mustang Bio Inc (MBIO) Statistics
Mustang Bio (MBIO) has a market cap of $3.20M. It holds $14.28M more cash than debt, 446.70% of its market cap. Revenue fell 100.00% over the last 12 months from the 12 months before.
Total Valuation
| Market Cap | $3.20M |
|---|---|
| Latest price (Nov 17, 2026) | $0.39 |
Key Dates
The next earnings report is expected on Mar 17, 2027, covering the quarter ending Dec 31, 2026.
| Next Earnings Date | Mar 17, 2027 (expected) |
|---|---|
| Last Earnings Date | Nov 5, 2026 |
| Fiscal Year End | December |
Price Statistics
The stock is down 67.96% over 52 weeks and trades 11.36% below its 50-day average.
| Beta (1Y) | 0.99 |
|---|---|
| 52-Week Change | -67.96% |
| 1-Month Change | +4.80% |
| 3-Month Change | -31.90% |
| 6-Month Change | -39.10% |
| 5-Year Change | -99.98% |
| Total Return (1Y) | -67.96% |
| Total Return (3Y CAGR) | -83.13% |
| Total Return (5Y CAGR) | -81.22% |
| Max Drawdown (1Y) | -74.50% |
| Max Drawdown (3Y) | -99.57% |
| Sharpe Ratio (1Y) | -1.73 |
| Correlation with SPY (1Y) | 0.20 |
| 50-Day Average | $0.44 |
| 200-Day Average | $0.65 |
| 52-Week Range | $0.35 to $1.43 |
| RSI (14 Days) | 44.7 |
| Average Volume (20 Days) | 35.61K |
The 5-year change compares month-end closes, adjusted for splits, through Oct 2026.
Returns and Efficiency
Return on equity is -53.58% and return on assets is -24.03% over the last 12 months.
| Return on Equity (ROE) | -53.58% |
|---|---|
| Return on Assets (ROA) | -24.03% |
| ROIC (5Y Average) | -20.16% |
Scores
MBIO has a Piotroski F-Score of 1 of 9, in the weak band of 0 to 2.
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Piotroski F-Score | 1 of 9 |
|---|---|
| Piotroski Strength | Weak |
Income Statement
Revenue was $0 over the last 12 months.
| Revenue | $0 |
|---|---|
| Revenue Growth (YoY) | -100.00% |
| Operating Income | -$3.96M |
| Pretax Income | -$3.53M |
| Net Income | -$3.53M |
| Reported EPS (TTM) | -$0.52 |
Trailing 12 months through Sep 30, 2026.
Balance Sheet
Shareholder equity funds 44.89% of the $14.68M in total assets.
| Cash and Equivalents | $14.28M |
|---|---|
| Total Debt | $0 |
| Net Cash | $14.28M |
| Net Cash Per Share | $2.12 |
| Working Capital | -$7.95M |
| Shareholder Equity | $6.59M |
| Book Value Per Share | $0.98 |
| Total Assets | $14.68M |
| Total Liabilities | $8.10M |
Balance sheet as of Sep 30, 2026.
Cash Flow
| Operating Cash Flow | -$4.57M |
|---|---|
| FCF Per Share | -$0.68 |
Trailing 12 months through Sep 30, 2026.
Dividends and Yields
MBIO does not pay a dividend.
| Buyback Yield | 5.28% |
|---|---|
| Shareholder Yield | 5.28% |
Stock Splits
The last split was a 1-for-50 reverse split on Jan 16, 2025.
| Last Split Date | Jan 16, 2025 |
|---|---|
| Split Type | Reverse split |
| Split Ratio | 1:50 |
Price Target
Analyst price targets are part of paid GNG plans. See plans
Frequently Asked Questions About MBIO
What is MBIO's market cap?
Mustang Bio has a market cap of $3.20M.
How many shares of MBIO are outstanding?
Mustang Bio has 6.74M shares outstanding. The count is up 7.92% from a year earlier.
Does MBIO pay a dividend?
No. Mustang Bio does not pay a dividend.
How much debt does MBIO have?
Mustang Bio has $0 of total debt and $14.28M of cash and equivalents, a net cash position of $14.28M.
MBIO pages: Overview, Charting, Earnings, Financials, Statistics, Competitors